
Translational pharmacology pursues research at the interface of non-clinical and clinical sciences. Our scientific focus is the personalization of drug therapy for chronic diseases. We investigate mechanisms of variability in therapeutic and adverse drug effects using laboratory experiments and carefully conducted proof-of-concept clinical studies.
We are particularly interested in lipid mediators within the eicosanoid biosynthetic response pathway. Most cells in the organism can synthesize eicosanoids, which play important regulatory roles in many physiological and pathological processes. These include inflammation, inflammatory pain, blood pressure regulation, atherosclerosis, thrombosis, tumor growth, and immunity. We conduct deep-phenotyping studies in model systems and humans, involving precise measurements of molecular network topologies and dynamics using omics technologies.
Selected Publication: Publications
Recent Publications: PubMed
Clinical Research Studies: Clinical Studies
Tilo Grosser, M.D.
Professor and Chair of Translational Pharmacology
Team Assistant
Carolin Mönter
carolin.moenter@uni-bielefeld.de
+49 521 106-86213
Office: R.2 B2-215
Systems Pharmacology
Lenny Ferrer, Ph.D.
Viktoria Fulek, M.Sc.
Vanessa Schmidt, Ph.D.
Michelle Schwab, M.Sc.
Cardiovascular Pharmacology
Jörg Wegener, Ph.D., Senior Lecturer
(Curriculum development Pharmacotherapy)
Lina Broeckelmann, B.Sc.
Immunology
Bianca Jütte, PhD
Till Knauf, cand. med.
Bioinformatics
Fabian Banze, B.Sc.
Clinical Research
Insa Wingendorf, MPH
Sarah Guttmann, PhD